Choosing wisely: Setting up clinical trials and research networks in India
Choosing wisely: Setting up clinical trials and research networks in India
The concept of 'choosing wisely' with cancer care in India
Community based cancer prevention and the contribution of the environment to cancer
The work of Can Support in India
Choosing wisely with breast cancer in India
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC
BCG dosing for bladder cancer: Standard frequency schedule correct
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC
The future of cancer care in India
Choosing wisely: Lung adenocarcinoma